• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿扑吗啡对帕金森病吞咽障碍的中枢多巴胺能刺激作用。

Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease.

作者信息

Tison F, Wiart L, Guatterie M, Fouillet N, Lozano V, Henry P, Barat M

机构信息

Département de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, France.

出版信息

Mov Disord. 1996 Nov;11(6):729-32. doi: 10.1002/mds.870110622.

DOI:10.1002/mds.870110622
PMID:8914103
Abstract

Swallowing disorders are common in Parkinson's disease but are of obscure and complex nature and pathophysiology. The effect of central dopaminergic stimulation on disordered swallowing is not well known. We studied the effects of apomorphine (in combination with domperidone) on buccolinguofacial motoricity and on various swallowing stages by using videofluoroscopy in eight patients with dysphagia. Swallowing abnormalities more frequently encountered were vallecular stasis (n = 7), fragmentation of the bolus (n = 7), and buccal stagnation of the bolus. Apomorphine improved vallecular stasis and fragmentation in about half the cases and improved buccal stagnation in all cases. Direct laryngeal penetration was found in three cases and improved in two of them. The total swallowing duration was improved by apomorphine in a subset of patients (n = 5). This improvement correlated with an improvement of the buccolinguofacial motoricity and was combined with an improvement of pharyngeal transit time. Thus central dopaminergic stimulation by apomorphine improved swallowing in a subgroup of patients, mainly in its early stages.

摘要

吞咽障碍在帕金森病中很常见,但性质和病理生理机制不明且复杂。中枢多巴胺能刺激对吞咽障碍的影响尚不清楚。我们通过视频荧光吞咽造影术研究了阿扑吗啡(联合多潘立酮)对8例吞咽困难患者颊舌面部运动功能及各个吞咽阶段的影响。更常见的吞咽异常表现为会厌谷淤滞(7例)、食团破碎(7例)和食团颊部停滞。阿扑吗啡在约半数病例中改善了会厌谷淤滞和食团破碎,在所有病例中均改善了食团颊部停滞。3例出现直接喉穿透,其中2例有所改善。阿扑吗啡使部分患者(5例)的总吞咽时间缩短。这种改善与颊舌面部运动功能的改善相关,并伴有咽部通过时间的改善。因此,阿扑吗啡引起的中枢多巴胺能刺激改善了部分患者的吞咽功能,主要是在早期阶段。

相似文献

1
Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease.阿扑吗啡对帕金森病吞咽障碍的中枢多巴胺能刺激作用。
Mov Disord. 1996 Nov;11(6):729-32. doi: 10.1002/mds.870110622.
2
Apomorphine-induced penile erections in Parkinson's disease.阿扑吗啡诱发帕金森病患者阴茎勃起
Mov Disord. 1998 May;13(3):536-9. doi: 10.1002/mds.870130326.
3
The pragmatic use of apomorphine at the end of life.在生命末期合理使用阿扑吗啡。
Palliat Med. 2009 Dec;23(8):777-9. doi: 10.1177/0269216309106979. Epub 2009 Oct 16.
4
Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.阿扑吗啡单一疗法治疗帕金森病难治性运动并发症:64例患者的长期随访研究
Mov Disord. 2002 Nov;17(6):1235-41. doi: 10.1002/mds.10281.
5
Apomorphine continuous stimulation in Parkinson's disease: receptor desensitization as a possible mechanism of reduced motor response.阿扑吗啡持续刺激治疗帕金森病:受体脱敏作为运动反应降低的一种可能机制
J Neural Transm Suppl. 1995;45:133-6.
6
[Effect of apomorphine on the bladder of parkinsonian patients].[阿扑吗啡对帕金森病患者膀胱的影响]
J Urol (Paris). 1992;98(1):25-9.
7
[Apomorphine for treatment of "off-periods" in Parkinson's disease].[阿扑吗啡用于治疗帕金森病的“关期”]
Harefuah. 1999 Nov 15;137(10):444-6, 512, 511.
8
Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease.
Adv Neurol. 1999;80:545-8.
9
Differential response in choice reaction time following apomorphine based on prior dopaminergic treatment.基于先前多巴胺能治疗,阿扑吗啡后选择反应时间的差异反应。
Acta Neurol Scand. 2004 May;109(5):348-54. doi: 10.1046/j.1600-0404.2003.00231.x.
10
[Subcutaneous apomorphine infusion in the treatment of Parkinson disease].皮下注射阿扑吗啡治疗帕金森病
Schweiz Rundsch Med Prax. 1992 Aug 25;81(35):1011-5.

引用本文的文献

1
Effects of the continuous subcutaneous infusion of foslevodopa-foscarbidopa on swallowing in patients with Parkinson's disease.持续皮下输注左旋多巴-卡比多巴对帕金森病患者吞咽功能的影响。
Clin Park Relat Disord. 2025 Jul 29;13:100378. doi: 10.1016/j.prdoa.2025.100378. eCollection 2025.
2
The effect of rasagiline on swallowing function in Parkinson's disease.雷沙吉兰对帕金森病吞咽功能的影响。
Heliyon. 2023 Dec 12;10(1):e23407. doi: 10.1016/j.heliyon.2023.e23407. eCollection 2024 Jan 15.
3
The effects of safinamide on dysphagia in Parkinson's disease.
沙芬酰胺对帕金森病吞咽困难的影响。
PLoS One. 2023 May 25;18(5):e0286066. doi: 10.1371/journal.pone.0286066. eCollection 2023.
4
Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson's Disease.非麦角类多巴胺激动剂治疗帕金森病运动及非运动症状的治疗进展。
Curr Neuropharmacol. 2023;21(5):1224-1240. doi: 10.2174/1570159X20666220915091022.
5
Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics.帕金森病中的胃肠功能障碍:当前及潜在治疗方法
J Pers Med. 2022 Jan 21;12(2):144. doi: 10.3390/jpm12020144.
6
Effectiveness of Interventions for Dysphagia in Parkinson Disease: A Systematic Review.帕金森病吞咽障碍干预措施的有效性:系统评价。
Am J Speech Lang Pathol. 2022 Jan 18;31(1):463-485. doi: 10.1044/2021_AJSLP-21-00145. Epub 2021 Dec 10.
7
Potential Prognostic Impact of Dopamine Receptor D1 () Polymorphism in Post-stroke Outcome in the Elderly.多巴胺受体D1()多态性对老年卒中后预后的潜在预后影响。
Front Neurol. 2021 Jun 30;12:675060. doi: 10.3389/fneur.2021.675060. eCollection 2021.
8
Gastrointestinal dysfunction in the synucleinopathies.神经核蛋白病中的胃肠道功能障碍。
Clin Auton Res. 2021 Feb;31(1):77-99. doi: 10.1007/s10286-020-00745-7. Epub 2020 Nov 27.
9
A comprehensive review of the diagnosis and treatment of Parkinson's disease dysphagia and aspiration.帕金森病吞咽困难和吸入症的诊断与治疗的全面综述。
Expert Rev Gastroenterol Hepatol. 2020 Jun;14(6):411-424. doi: 10.1080/17474124.2020.1769475.
10
Impact of Residual Drug in the Pharynx on the Delayed-On Phenomenon in Parkinson's Disease Patients.咽部残留药物对帕金森病患者延迟现象的影响。
Mov Disord Clin Pract. 2020 Feb 27;7(3):273-278. doi: 10.1002/mdc3.12908. eCollection 2020 Apr.